Further, given the role of healthcare professionals, such as pharmacists, in managing diabetes collaboratively with patients, it is important to further elucidate whether switching to patch-like basal-bolus insulin delivery devices provides benefits to patients in real-world settings. Here, INS is linked to diabetes mellitus.